![]() Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. | ||||
Founding Date | Founding Date 2012 | Founding Date N/A | Founding Date N/A | Founding Date 2020 |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Farmington, US HQ | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations San Francisco, US HQ | Locations Boston, US HQ |
Employees | Employees 12 | Employees 29723% increase | Employees 254% increase | Employees 432% increase |
Funding | ||||
Latest funding round | Latest funding round $ 1.4m (about 7 years ago) | Latest funding round N/A | Latest funding round $ 2m (about 19 years ago) | Latest funding round $ 5.4m (almost 6 years ago) |
Total funding raised | Total funding raised $ 1.6m | Total funding raised $ 267.3m | Total funding raised $ 2m | Total funding raised $ 5.4m |

Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View company
Prosetta Corporation operates as a biopharmaceutical company in the United States.
View companyManifold Bio is a biotechnology company.
View company